Nonsense Mutation in Exon-19 of GPIIb Associated with Thrombasthenic Phenotype. Failure of GPIIb(Δ597-1008) to Form Stable Complexes with GPIIIa

Summary

We report the molecular genetic analysis of a patient with thrombasthenic phenotype. The lack of surface platelet GPIIb-IIIa complexes and the presence of GPIIIa suggested it was a case of type I Glanzmann’s thrombasthenia due to a mutation in GPIIb. Single stranded conformational polymorphism analysis (SSCP) of exon-19 of GPIIb showed polymorphic DNA bands. The DNA sequence of exon-19 revealed the presence of a homozygous C1882T transition that changes residue R597 to STOP codon. Since no other mutations were found in either GPIIb or GPIIIa it is concluded that the C1882T substitution in GPIIb is responsible for the thrombasthenic phenotype of the patient. The lack of platelet GPIIb-mRNA in the proband indicates instability of the [C1882T]GPIIb-mRNA. Coexpression of normal GPIIIa and GPIIb(Δ597-1008) in CHO cells failed to show surface expression of GPIIb(Δ597-1008)-IIIa complexes. Immunoprecipitation analysis demonstrated that GPIIb(Δ597-1008) may indeed complex GPIIIa; however, the association is either unstable or incapable of progressing along the secretory pathway.

Keywords

Glanzmann’s thrombasthenia - GPIIb - GPIIIa - fibrinogen receptor - green fluorescence protein

• References

• 1 Glanzmann E. Hereditare Hemorrhagische Thrombasthenie: ein Beitrag zur Pathologie der Blut Plättchen. J Kinderke 1918; 88: 113-41.
• 2 Nurden AT, Caen JP. Specific roles for platelet surface glycoproteins in platelet functions. Nature 1975; 255: 720-2.
• 3 Chen YQ, Trikha M, Gao X, Bazaz R, Porter AT, Timar J, Honn KV. Ectopic expression of platelet integrin α_IIbβ₃ in tumor cells from various species and histological origin. Int J Cancer 1997; 72: 642-8.
• 4 Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988; 71: 831-43.
• 5 Pytela RP, Pierschbacher MD, Ginsberg MH, Plow EF, Ruoslahti E. Platelet membrane glycoprotein IIb/IIIa: Member of a family of Arg-Gly-Aspspecific adhesion receptors. Science 1986; 231: 1559-62.
• 6 French DL. The molecular genetics of Glanzmann’s thrombasthenia. Platelets 1998; 09: 5-20.
• 7 Caen JP. Glanzmann’s thrombasthenia. Clin Haematol 1972; 01: 383-92.
• 8 Nurden AT, Rosa JP, Fournier D, Legrand C, Didry D, Parquet A, Pidard D. A variant of Glanzmann’s thrombasthenia with abnormal GPIIb-IIIa complexes in the platelet membrane. J Clin Invest 1987; 79: 962-9.
• 9 Ferrer M, Tao J, Iruin G, Ayuso MS, González-Rodríguez J, Parrilla R, González-Manchón C. Truncation of GPIIIa (Δ 616-762) prevents complex formation with GPIIb. Novel mutation in exon-11 of GPIIIa associated with thrombasthenia Blood 1998; 92: 4712-20.
• 10 Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 05: 874-9.
• 11 Jin Y, Dietz HC, Nurden A, Bray PF. Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood 1993; 82: 2281-8.
• 12 Marchuk D, Drumm M, Saulino A, Collins FS. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res 1991; 19: 1154.
• 13 Marck C. A “C” program for the fast analysis of DNA and protein sequences on the Apple Macintosh family of computers. Nucleic Acids Res 1988; 16: 1829-36.
• 14 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
• 15 Gelmini S, Orlando C, Sestini R, Vona G, Pinzani P, Ruocco L, Pazzagli M. Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification. Clin Chem 1997; 43: 752-8.
• 16 Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 1989; 77: 61-8.
• 17 Gulick T. Transfection using DEAE-dextran. In: Current Protocols in Molecular Biology. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. eds. New York: Wiley; 1997. 9.2.1.
• 18 Vinciguerra C, Khelief A, Alemany M, Morle F, Grenier C, Uzan G, Guling D, Dechavanne M, Negrier C. A nonsense mutation in the GPIIb heavy chain (Ser870→STOP) impairs platelet GPIIb-IIIa expression. Br J Haematol 1996; 95: 399-407.
• 19 Iwamoto S, Nishiumi E, Kajii E, Ikemoto S. An exon 28 mutation resulting in alternative splicing of the glycoprotein IIb transcript and Glanzmann’s thrombasthenia. Blood 1994; 83: 1017-23.
• 20 Tomiyama Y, Kashiwagi H, Kosugi S, Shigara M, Kanayama Y, Kurata Y, Matsuzawa Y. Abnormal processing of the glycoprotein IIb transcript due to a nonsense mutation in exon 17 associated with Glanzmann’s thrombasthenia. Thromb Haemost 1995; 73: 756-62.
• 21 González-Manchón C, Fernández-Pinel M, Arias-Salgado EG, Ferrer M, Alvarez MV, García-Muñoz S, Ayuso MS, Parrilla R. Molecular genetic analysis of a compound heterozygote for the GPIIb gene associated with Glanzmann’s trombasthenia. Disruption of the 674-687 disulfide bridge in GPIIb prevents surface expression of GPIIb-IIIa. Blood 1999; 93: 866-75.
• 22 Kato A, Yamamoto K, Miazaki S, Jung SM, Moroi M, Aoki N. Molecular basis for Glanzmann’s thrombasthenia (GT) in a compound heterozygote with glycoprotein IIb gene: A proposal for classification of GT based on the biosynthetic pathway of glycoprotein IIb-IIIa complex. Blood 1992; 79: 3212-8.
• 23 Cooper DN. Human gene mutations affecting RNA processing and translation. Ann Med 1993; 25: 11-7.
• 24 Gu JM, Xu WF, Wang XD, Wu QY, Chi CW, Ruan CG. Identification of a nonsense mutation at amino acid 584-arginine of platelet glycoprotein IIb in patients with type I Glanzmann thrombasthenia. Br J Haematol 1993; 83: 442-9.
• 25 Dietz HC, Valle D, Francomano CA, Kendzior Jr RJ, Pyeritz RE, Cutting GR. The skipping of constitutive exons in vivo induced by nonsense mutations. Science 1993; 259: 680-3.
• 26 Frachet P, Duperray A, Delachanal E, Marguerie G. Role of the transmembrane and cytoplasmic domains in the assembly and surface exposure of the platelet integrin IIb-IIIa. Biochemistry 1992; 31: 2408-15.
• 27 Bennett JS, Kolodziej MA, Vilaire G, Poncz M. Determinants of intracellular fate of truncated forms of the platelet glycoproteins IIb and IIIa. J Biol Chem 1993; 268: 3580-5.
• 28 Rosenberg N, Yatuv R, Peretz H, Zivelin A, Seligsohn U. Glycoprotein (GP)IIb gene causing Glanzmann thrombasthenia, suggests that a region in the C-terminal of the heavy chain is important for GPIIb/IIIa complex formation. Thromb Haemost 2001; Suppl: abstract OC87.
• 29 Mitchell B, Li J, Weiss HJ, Coller BS, French DL. A Glanzmann thrombasthenia mutation in αIIb resulting in deletion of the transmembrane domain impairs α_IIbβ₃ complex formation and processing. Thromb Haemost 2001; Suppl: abstract P1182.
• 30 Ferrer M, Fernández M, González-Manchón C, González J, Ayuso MS, Parrilla R. A novel GPIIb mutation (Arg358→His) prevents surface expression of GPIIb-IIIa complex (integrin α_IIbβ₃). Dominant negative effect of the mutant subunit. Thromb Hemost 1996; 76: 292-301.
• 31 Arias-Salgado EG, Butta N, González-Manchón C, Larrucea S, Ayuso MS, Parrilla R. Competition between normal [674C] and mutant [674R]GPIIb subunits. Role of the molecular chaperone BiP in the processing of GPIIbIIIa complexes. Blood 2001; 97: 2640-7.
• 32 Grimaldi CM, Chen F, Scudder LE, Coller BS, French DL. A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (β₃) in a chinese patient with Glanzmann’s thrombasthenia. Blood 1996; 88: 1666-75.
• 33 Chen YP, Djaffar I, Pidard D, Steiner B, Cieutat AM, Caen JP, Rosa JP. Ser752→Pro mutation in the cytoplasmic domain of integrin β₃ subunit and defective activation of platelet integrin α_IIbβ₃ (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci USA 1992; 89: 10169-73.